The plasticity of pancreatic cancer stem cells: implications in therapeutic resistance
Open Access
- 28 August 2021
- journal article
- review article
- Published by Springer Science and Business Media LLC in Cancer and Metastasis Reviews
- Vol. 40 (3), 691-720
- https://doi.org/10.1007/s10555-021-09979-x
Abstract
The ever-growing perception of cancer stem cells (CSCs) as a plastic state rather than a hardwired defined entity has evolved our understanding of the functional and biological plasticity of these elusive components in malignancies. Pancreatic cancer (PC), based on its biological features and clinical evolution, is a prototypical example of a CSC-driven disease. Since the discovery of pancreatic CSCs (PCSCs) in 2007, evidence has unraveled their control over many facets of the natural history of PC, including primary tumor growth, metastatic progression, disease recurrence, and acquired drug resistance. Consequently, the current near-ubiquitous treatment regimens for PC using aggressive cytotoxic agents, aimed at ‘‘tumor debulking’’ rather than eradication of CSCs, have proven ineffective in providing clinically convincing improvements in patients with this dreadful disease. Herein, we review the key hallmarks as well as the intrinsic and extrinsic resistance mechanisms of CSCs that mediate treatment failure in PC and enlist the potential CSC-targeting ‘natural agents’ that are gaining popularity in recent years. A better understanding of the molecular and functional landscape of PCSC-intrinsic evasion of chemotherapeutic drugs offers a facile opportunity for treating PC, an intractable cancer with a grim prognosis and in dire need of effective therapeutic advances.Keywords
Funding Information
- Hamad Medical Corporation (#16354)
- Hamad Medical Corporation
This publication has 330 references indexed in Scilit:
- LGR5 is Expressed by Ewing Sarcoma and Potentiates Wnt/β-Catenin SignalingFrontiers in Oncology, 2013
- Alteration of pancreatic cancer cell functions by tumor-stromal cell interactionFrontiers in Physiology, 2013
- Sulforaphane regulates self-renewal of pancreatic cancer stem cells through the modulation of Sonic hedgehog–GLI pathwayMolecular and Cellular Biochemistry, 2012
- Regulation of CD133 by HDAC6 Promotes β-Catenin Signaling to Suppress Cancer Cell DifferentiationCell Reports, 2012
- EMT and Dissemination Precede Pancreatic Tumor FormationCell, 2012
- Evidence for partial epithelial‐to‐mesenchymal transition (pEMT) and recruitment of motile blastoderm edge cells during avian epibolyDevelopmental Dynamics, 2011
- Bmi-1 Is a Crucial Regulator of Prostate Stem Cell Self-Renewal and Malignant TransformationCell Stem Cell, 2010
- CD44‐positive cells are responsible for gemcitabine resistance in pancreatic cancer cellsInternational Journal of Cancer, 2009
- Characterization and functional analysis of a slow cycling stem cell-like subpopulation in pancreas adenocarcinomaClinical & Experimental Metastasis, 2009
- The Epithelial-Mesenchymal Transition Generates Cells with Properties of Stem CellsCell, 2008